Moxifloxacin: a review of its use in the management of bacterial infections.
about
Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.Moxifloxacin safety: an analysis of 14 years of clinical data.The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in KoreaUpgrading antibiotic use within a class: tradeoff between resistance and treatment success.Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradicationRapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosisAntimicrobial-resistant Streptococcus pneumoniae: trends and management.Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.Moxifloxacin Increases Heart Rate in Humans.Levofloxacin in the treatment of community-acquired pneumonia.Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis.Microbial transformations of antimicrobial quinolones and related drugs.The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials.Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies.Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapyTopoisomerases: Resistance versus Sensitivity, How Far We Can Go?Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A ReviewDrug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital.Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.Cure of Q fever pneumonia with moxifloxacin: case report.Aqueous penetration of orally and topically administered moxifloxacin.Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometryDexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.Vitreous and aqueous penetration of orally administered moxifloxacin in humans.Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate
P2860
Q33812856-A146F268-27B3-4B4C-92AC-C5266D82AB3DQ33843119-87CABDEF-11B9-41E5-BE17-FEED73295FABQ34310568-A763E5D5-BAF2-45E6-BF21-E87B357FEE2CQ34432129-7D23E395-E41C-4E6D-8785-0B650D442527Q34687139-88C41559-590F-4A30-BCA0-20E05CCEBC32Q35023339-CD9DC1F2-5258-4049-83C9-8E9FC551A13FQ35594239-2E8297B6-0600-4ADD-974E-041AB0AB9A1EQ35771863-04FD894F-5E17-474D-9364-BC9C443686B3Q36067627-0724A39D-C0AE-4A7D-A552-DC94F95B6ED3Q36870838-030AC3BA-CFC5-4168-BF8F-4D964EC70F76Q37291341-A1E47E54-B601-4517-BD0E-2DB9C2CC3BE9Q37577369-E1336747-516C-4C5D-8A8D-BDCF77DD1058Q37729919-6040FEF3-5C47-4BB5-8F35-C5577E3B7289Q37747381-CA9C1950-4A08-4F7C-8EF8-3739B44AA8D7Q37857355-9CB6F1AF-5023-4642-8DFB-B6C2CE9D9F4BQ38046140-AEAA666C-E4B7-4B9E-AE30-5CDFF6E4CB84Q38125597-1C6CA563-031C-430F-9E38-5D7CFF40E716Q38488589-AB79322F-DDE4-43F9-8546-8BEFC3D40CF0Q38842229-82952CF5-9678-481E-8E10-9C1B1413FF0FQ38968355-4F8BCBFA-A80D-4130-B80D-F36B1D1C359AQ39143340-65B8D90A-9F12-46A9-AFB9-13CEBC2E8FBDQ40055329-FACF1A5E-3B76-43C8-A393-D83E4349163CQ40225402-F35A3C8C-981A-4D59-91D8-9A7D25DBB678Q40497592-4836042E-9574-4B5F-83F2-AAD6921998F9Q41369432-281C3277-57DC-433C-B2CB-50F0A8F92375Q41760699-2F8CE2FE-5444-4167-8009-0270A169ECC0Q42082902-A059FD83-53E8-4E9F-80F8-FCBBFD078DF8Q44550456-45CD7B5C-865C-449D-8319-C8D44588D009Q46099612-7E9962C6-0D64-45A6-988A-E2287ADEFB13Q57543731-73B73A9F-0C5A-4D2D-BE0B-EDE2F0A9EB12
P2860
Moxifloxacin: a review of its use in the management of bacterial infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Moxifloxacin: a review of its use in the management of bacterial infections.
@ast
Moxifloxacin: a review of its use in the management of bacterial infections.
@en
type
label
Moxifloxacin: a review of its use in the management of bacterial infections.
@ast
Moxifloxacin: a review of its use in the management of bacterial infections.
@en
prefLabel
Moxifloxacin: a review of its use in the management of bacterial infections.
@ast
Moxifloxacin: a review of its use in the management of bacterial infections.
@en
P1433
P1476
Moxifloxacin: a review of its use in the management of bacterial infections.
@en
P304
P356
10.2165/00003495-200464200-00006
P577
2004-01-01T00:00:00Z
P6179
1017552627